Truxton

Truxton Pharmaceuticals was a specialty pharmaceutical company based in New Jersey that focused on the manufacturing, distribution, and private labeling of generic prescription medications. The company maintained a portfolio of small molecule drugs across several therapeutic areas, including neurology, psychiatry, and pain management. Key products in their catalog included generic versions of phenobarbital, amitriptyline, and promethazine. In addition to its own product line, Truxton provided contract manufacturing services to other pharmaceutical entities. The company ceased most of its active operations in the late 2010s following regulatory challenges and product recalls. Its business model was centered on providing cost-effective generic alternatives for established therapeutic needs in the United States.